Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 3.79 CAD -2.32%
Market Cap: 1.5B CAD

Cronos Group Inc
Investor Relations

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

Show more
Loading
CRON
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Record Quarter: Cronos delivered record net revenue, gross profit, and adjusted EBITDA in Q3 2025, highlighting strong performance in core markets.

Gross Margin Surge: Gross margin improved sharply to 50%, up 19 percentage points from last year, driven by better sales mix, higher volumes, and production efficiencies.

Canada Highlights: Canadian flower sales were down due to supply constraints, but this was offset by strong growth in edibles and vapes; Spinach became #2 cannabis brand in Canada.

Israel Momentum: Record net revenue in Israel, with flagship PEACE NATURALS remaining the #1 medical cannabis brand and patient count in Israel returning to growth.

GrowCo Expansion: The Phase 2 expansion at GrowCo is complete, expected to ease flower supply constraints and drive future growth, with a 70% increase in flower capacity.

Operating Expenses Down: Operating expenses fell by $4.3 million year-over-year due to cost management.

Strong Balance Sheet: Cronos ended the quarter with $824 million in cash and investments and no debt.

Key Financials
Net Revenue
$36.3 million
Gross Profit
$18.3 million
Gross Margin
50%
Operating Expenses
$18.6 million
Adjusted EBITDA
$5.7 million
Cash, Cash Equivalents and Short-Term Investments
$824 million
Share Repurchases
$1.9 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Michael Ryan Gorenstein J.D.
President, CEO & Chairman
No Bio Available
Mr. James Holm
Chief Financial Officer
No Bio Available
Mr. Jeffrey David Jacobson
Chief Growth Officer
No Bio Available
Ms. Anna Shlimak
Chief Strategy Officer
No Bio Available
Mr. James Andrew McGinness III
VP, Controller & Principal Accounting Officer
No Bio Available
Mr. Shayne J. Laidlaw
Director of Investor Relations & Strategy
No Bio Available
Mr. Terry Gregory-Joseph Doucet
General Counsel & Corporate Secretary
No Bio Available
Ms. Shannon Buggy
Senior VP & Global Head of People
No Bio Available
Mr. Arye Weigensberg
Senior VP and Head of Research & Development
No Bio Available
Mr. Adam Wagner
Senior VP & Head of Cronos Israel
No Bio Available

Contacts

Address
ONTARIO
TORONTO
111 Peter Street, Suite 300
Contacts
+4165040004.0
thecronosgroup.com